Researcher.Life Logo

Immunopharmacology and Immunotoxicology : Impact Factor & More

eISSN: 1532-2513pISSN: 0892-3973

Aims and Scope of Immunopharmacology and Immunotoxicology

Immunopharmacology and Immunotoxicology is a bimonthly peer-reviewed medical journal that covers preclinical and clinical studies on the regulatory effects of various agents on immunocompetent cells, as well as the immunotoxicity exerted by xenobiotics and drugs. Hence, the journal encompasses a broad range of pathologies (e.g. acute and chronic infections, allergy, autoimmunity, cancer, degenerative disorders, inflammation, and primary and secondary immunodeficiencies). It is published by Informa. Less

Key Metrics

CiteScore
4.7
Impact Factor
< 5
SJR
Q3Immunology
SNIP
0.83
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Immunopharmacology and Immunotoxicology

Immunopharmacology and Immunotoxicology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year1987
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Immunopharmacology and Immunotoxicology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Immunopharmacology and Immunotoxicology

Pharmacovigilance Analysis of Vonoprazan: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System Database.
  • 17 May 2026
  • Immunopharmacology and immunotoxicology
Modulation of ET1/NF-κB/IL-6/STAT-4/AP-1 pathway by ambrisentan alleviates isoprenaline-induced myocardial injury
  • 15 May 2026
  • Immunopharmacology and Immunotoxicology
The anti-inflammatory activity and toxicological safety of synthetic chalcone derivatives in preclinical trials
  • 12 May 2026
  • Immunopharmacology and Immunotoxicology
Effect of zinc oxide nanoparticles on circulating neutrophils in carbon tetrachloride (CCl4) induced liver fibrosis in rats
  • 12 May 2026
  • Immunopharmacology and Immunotoxicology
Rituximab Beyond Oncology: Targeting B-Cell-Mediated Immunomodulatory Therapy in Neurodegenerative and Neuropsychiatric Disorders
  • 11 May 2026
  • Immunopharmacology and Immunotoxicology
Mono(2-ethylhexyl) phthalate modulates bone marrow-derived APCs and exacerbates allergic lung inflammation via PPARγ-dependent pro-inflammatory signaling
  • 11 May 2026
  • Immunopharmacology and Immunotoxicology
Pharmacovigilance Analysis of Vonoprazan: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System Database.
  • 17 May 2026
  • Immunopharmacology and immunotoxicology
Modulation of ET1/NF-κB/IL-6/STAT-4/AP-1 pathway by ambrisentan alleviates isoprenaline-induced myocardial injury
  • 15 May 2026
  • Immunopharmacology and Immunotoxicology
The anti-inflammatory activity and toxicological safety of synthetic chalcone derivatives in preclinical trials
  • 12 May 2026
  • Immunopharmacology and Immunotoxicology
Effect of zinc oxide nanoparticles on circulating neutrophils in carbon tetrachloride (CCl4) induced liver fibrosis in rats
  • 12 May 2026
  • Immunopharmacology and Immunotoxicology
Rituximab Beyond Oncology: Targeting B-Cell-Mediated Immunomodulatory Therapy in Neurodegenerative and Neuropsychiatric Disorders
  • 11 May 2026
  • Immunopharmacology and Immunotoxicology
Mono(2-ethylhexyl) phthalate modulates bone marrow-derived APCs and exacerbates allergic lung inflammation via PPARγ-dependent pro-inflammatory signaling
  • 11 May 2026
  • Immunopharmacology and Immunotoxicology

FAQs on Immunopharmacology and Immunotoxicology